89bio, Inc. (ETNB) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

89bio, Inc.

ETNB

NASDAQ

Unprofitable

Biotechnology

Next Earning date - 08 May 2025

Biotechnology

Next Earning date - 08 May 2025

6.94USD

0.04 ( 0.58%)

Market Closed (as of Apr 25, 20:00 EDT)

Relative Strenght

Volume Buzz

-58%

Earning Acce

Dist 52w H.

41%

Overview Chart

Quote Panel

Updated April 28, 2025

1W 5.95 % 1M -4.54 % 3M -20.50 % 1Y -18.64 %

Key Metrics

Market Cap
1.01B
Shares Outstanding
145.98M
Share in Float
140.34M
Dividende
0

Earning Date
08 May 2025
Price Target
6.94
Average Volume
2.16M
Beta
1.291

Range
4.16-11.84
Industry
Biotechnology
Website
https://www.89bio.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

0.00x

P/S Ratio

2.01x

P/B Ratio

0.1

Debt/Equity

0.0%

Net Margin

$-3.5

EPS

How ETNB compares to sector?

P/E Ratio

Fundamentals

Relative Strength

ETNB

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

ETNB

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$3M

NaN%

2025-Revenue

$2.15

-110%

2025-EPS

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

0.00(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Wolfe Research

initialise

Previous: Not converted

2025-02-03

Now: Outperform

Raymond James

upgrade

Previous: Not converted

2022-05-12

Now: Strong Buy

Earnings Growth

YoY

Current

Estimates

Q1.23

N/A

-0.54
vs -1.26

Q2.23

N/A

-0.52
vs -1.23

Q3.23

N/A

-0.45
vs -0.57

Q4.23

N/A

-0.50
vs -0.48

Q1.24

N/A

-0.54
vs -0.54

Q2.24

N/A

-0.48
vs -0.52

Q3.24

N/A

-1.39
vs -0.45

Q4.24

N/A

-1.02
vs -0.50

Q1.25

N/A

-0.52
vs -0.54

Q2.25

N/A

-0.53
vs -0.48

Sales Growth

YoY

Current

Estimates

Q3.22

NA vs NA

Q4.22

NA vs NA

Q1.23

NA vs NA

Q2.23

NA vs NA

Q3.23

NA vs NA

Q4.23

234K vs NA

Q1.24

NA vs NA

Q2.24

NA vs NA

Q3.24

NA vs NA

Q4.24

-100%

NA vs 234K

Return on Equity

QoQ

Q1.23

-19%

-0.19
vs -0.16

Q2.23

-9%

-0.09
vs -0.19

Q3.23

-8%

-0.08
vs -0.09

Q4.23

-8%

-0.08
vs -0.08

Q1.24

-10%

-0.10
vs -0.08

Q2.24

-9%

-0.09
vs -0.10

Q3.24

-39%

-0.39
vs -0.09

Q4.24

-30%

-0.30
vs -0.39

Institutionnal Ownership

QoQ

Q1.23

174

174
vs 117

49%

Q2.23

168

168
vs 174

-3%

Q3.23

184

184
vs 168

10%

Q4.23

160

160
vs 184

-13%

Q1.24

161

161
vs 160

Q2.24

151

151
vs 161

-6%

Q3.24

150

150
vs 151

-1%

Q4.24

162

162
vs 150

Earnings Growth

Latest News

seekingalpha.com

4 hours ago

89bio: A Buy With Strong Market Opportunity In MASH And SHTG

zacks.com

10 hours ago

Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year?

zacks.com

10 hours ago

Should You Buy 89BIO (ETNB) After Golden Cross?

https://thefly.com

11 hours ago

89bio price target lowered by $8 at H.C. Wainwright, here's why

globenewswire.com

16 hours ago

89bio to Participate in the Leerink Partners Global Healthcare Conference

globenewswire.com

16 hours ago

89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

Company Description

6.94USD

N/A

0.00x

2.01x

0.1

0.0%

$-3.5

$3M

$2.15

Earnings Growth

Latest News

Company Description

6.94USD

N/A

0.00x

2.01x

0.1

0.0%

$-3.5